Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations. [electronic resource]
Producer: 20120525Description: 816-24 p. digitalISSN:- 1098-6596
- Adolescent
- Anti-HIV Agents -- administration & dosage
- Biological Availability
- Capsules
- Cohort Studies
- Dose-Response Relationship, Drug
- Female
- Gelatin
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- administration & dosage
- Humans
- Lopinavir -- administration & dosage
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Pregnancy Trimester, Second
- Pregnancy Trimester, Third
- Tablets
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.